On August 5, 2025, Vera Therapeutics, Inc. entered into a Sales Agreement with TD Securities $(USA)$ LLC ("TD Cowen") to offer and sell up to $200 million worth of its Class A common stock. The company is not obligated to sell any shares, and the agreement allows TD Cowen to sell shares through various methods including negotiated transactions and at-the-market offerings. The document does not specify the total number of shares or the price per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-173591), on August 05, 2025, and is solely responsible for the information contained therein.